Lung Cancer Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who are 18 years of age or older
• People whose general health and ability to carry out daily activities meets a specific performance standard (rated 0 or 1 on a scale used by doctors to measure this)
• People who have been confirmed through a tissue or cell sample test to have small cell lung cancer (SCLC)
• People whose cancer has spread extensively — for example, to the fluid around the lungs, to the other lung, or to other parts of the body outside the chest
• People whose cancer has measurable tumours (as assessed by a specific medical imaging standard) before starting platinum-based chemotherapy
• People whose blood test results meet specific levels for white blood cells, platelets, and red blood cells (confirm with trial site)
• People whose kidney function test results fall within acceptable ranges (confirm with trial site)
• People whose liver function test results fall within acceptable ranges — slightly higher limits may apply if cancer has spread to the liver (confirm with trial site)
• People whose bilirubin levels fall within acceptable ranges — different limits may apply for people with a condition called Gilbert's syndrome (confirm with trial site)
• People who understand the research nature of the trial and are willing to sign a written consent form before any trial procedures begin

Who may not be able to join:

• People who have had major surgery within 14 days before starting the trial, or who have not yet recovered from the side effects of a prior surgery (a tumour biopsy is not considered major surgery)
• People who have an immune-suppressing condition, HIV/AIDS, or other diseases that weaken the immune system — testing for HIV, Hepatitis B, and Hepatitis C is required before enrolment
• People who have a known allergy or sensitivity to the trial drugs or closely related medicines
• People who have had a heart attack, or a blood clot in an artery or vein, within the 6 months before the trial baseline assessment
• People with severe or unstable chest pain (angina), or heart disease classified as Stage III or IV under a standard medical rating scale
• People with a history of heart failure (classified as Stage III or IV) within the 6 months before the trial baseline assessment
• People with poorly controlled irregular heartbeat (arrhythmia)

Important: Always verify eligibility with the trial site directly before applying.